Towards Improved Brain Tumor Treatment: Novel Therapeutic and Diagnostic Targets

Glioma is an extremely aggressive brain tumour with a short average patient survival time of around 15 months. Unfortunately, current treatment options are still not effective enough, resulting in high mortality rates. My goal is to improve treatment outcomes in glioma patients. In this study, I identified novel glioma biomarkers for gene therapy and early diagnosis while studying their molecular mechanisms. As medicine development approaches towards more personalised treatment, my findings could be beneficial for developing new gene therapy strategies, drugs or early detection methods that are less invasive and more sensitive.